Equities analysts predict that Celanese Co. (NYSE:CE) will report earnings per share of $2.49 for the current quarter, according to Zacks. Four analysts have made estimates for Celanese’s earnings. The highest EPS estimate is $2.77 and the lowest is $2.30. Celanese posted earnings of $2.79 per share during the same quarter last year, which suggests a negative year-over-year growth rate of 10.8%. The business is expected to issue its next earnings results on Monday, April 15th.
According to Zacks, analysts expect that Celanese will report full-year earnings of $10.41 per share for the current financial year, with EPS estimates ranging from $9.75 to $10.74. For the next fiscal year, analysts anticipate that the company will post earnings of $11.71 per share, with EPS estimates ranging from $10.55 to $12.20. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that cover Celanese.
Celanese (NYSE:CE) last announced its earnings results on Monday, January 28th. The basic materials company reported $2.38 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $2.40 by ($0.02). The business had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.72 billion. Celanese had a return on equity of 40.37% and a net margin of 16.87%. The firm’s revenue for the quarter was up 6.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.98 earnings per share.
NYSE:CE traded up $2.32 during mid-day trading on Wednesday, reaching $100.93. The stock had a trading volume of 27,262 shares, compared to its average volume of 973,556. The stock has a market capitalization of $12.79 billion, a price-to-earnings ratio of 9.17, a price-to-earnings-growth ratio of 0.95 and a beta of 1.32. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.62 and a quick ratio of 1.03. Celanese has a 12 month low of $82.91 and a 12 month high of $119.29.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Nuveen Asset Management LLC lifted its holdings in Celanese by 23.1% in the fourth quarter. Nuveen Asset Management LLC now owns 273,162 shares of the basic materials company’s stock valued at $24,576,000 after buying an additional 51,275 shares during the period. DNB Asset Management AS boosted its stake in Celanese by 20.1% in the fourth quarter. DNB Asset Management AS now owns 23,991 shares of the basic materials company’s stock valued at $2,158,000 after acquiring an additional 4,011 shares during the last quarter. Robeco Institutional Asset Management B.V. boosted its stake in Celanese by 14.6% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 71,746 shares of the basic materials company’s stock valued at $6,454,000 after acquiring an additional 9,143 shares during the last quarter. GSA Capital Partners LLP boosted its stake in Celanese by 106.6% in the third quarter. GSA Capital Partners LLP now owns 21,318 shares of the basic materials company’s stock valued at $2,430,000 after acquiring an additional 11,002 shares during the last quarter. Finally, Daiwa SB Investments Ltd. boosted its stake in Celanese by 121.8% in the fourth quarter. Daiwa SB Investments Ltd. now owns 1,730 shares of the basic materials company’s stock valued at $156,000 after acquiring an additional 950 shares during the last quarter. 96.45% of the stock is currently owned by hedge funds and other institutional investors.
Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through Engineered Materials, Acetate Tow, and Acetyl Chain segments. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics.
Recommended Story: Understanding each part of a balance sheet
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Celanese Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celanese and related companies with MarketBeat.com's FREE daily email newsletter.